Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |